Jaguar Health, Inc. (NASDAQ:JAGX) Q2 2021 Earnings Conference Call August 13, 2021 8:00 AM ET Company Participants Lisa Conte - President & Chief Executive Officer Carol Lizak - Senior Vice President, Finance & Chief Accounting Officer Ian Wendt - Chief Commercial Officer Conference Call Participants Operator Please standby, we're about to begin. Before I turn the call over to management, I'd like to remind you that management may make forward-looking statements relating to such matters as continued growth ...

Jaguar Health, Inc. (NASDAQ:JAGX) Q1 2021 Earnings Conference Call May 17, 2021 8:30 AM ET Company Participants Lisa Conte - President & Chief Executive Officer Carol Lizak - Senior Vice President, Finance & Chief Accounting Officer Peter Hodge - Senior Director of Investor Relations Conference Call Participants Operator Good day and welcome to the Jaguar Health Investor Webcast. Today's conference is being recorded. Before I turn the call over to management, I'd like to remind you that management may make ...

Jaguar Health, Inc. (NASDAQ:JAGX) Q3 2020 Earnings Conference Call November 16, 2020 8:30 AM ET Company Participants Lisa Conte - President & Chief Executive Officer Carol Lizak - Senior Vice President, Finance & Chief Accounting Officer Ian Wendt - Vice President, Commercial Strategy Pravin Chaturvedi - Chief Scientific Officer Michael Guy - Vice President, Preclinical & Nonclinical Studies Steven King - Chief Sustainable Supply Ethnobotanical Research and IP Officer Peter Hodge - Senior Director of Invest ...

Jaguar Health, Inc. (NASDAQ:JAGX) Q1 2020 Earnings Conference Call May 15, 2020 8:30 AM ET Company Participants Lisa Conte – Founder and Chief Executive Officer Carol Lizak – Senior Vice President-Finance and Chief Accounting Officer Ian Wendt – Vice President-Commercial Strategy Conference Call Participants Operator Welcome to the Jaguar Health Investor Conference Call. Before I turn the call over to management, IÂ'd like to remind you that management may make forward-looking statements relating to such ma ...

Jaguar Health, Inc. (NASDAQ:JAGX) Q4 2019 Results Earnings Conference Call April 6, 2020 8:30 AM ET Company Participants Lisa Conte - Founder, President and CEO Carol Lizak - Senior VP of Finance and Chief Accounting Officer Ian Wendt - Vice President, Commercial Strategy Steven King - Executive Vice President, Sustainable Supply, Ethnobotanical Research and Intellectual Property Pravin Chaturvedi - CSO Conference Call Participants Operator Good day and welcome to the Jaguar Health Investor Call. Today's co ...

Jaguar Health, Inc. Investor Presentation January 2019 Forward-Looking Statements This presentation contains forward-looking statements. All statements other than statements of historical facts contained in this presentation, including statements regarding the Company's plan to file an IND in 2H 2019 for lechlemer for the possible indication of diarrhea caused by cholera, the Company's belief that lechlemer may offer a possible Priority Review Voucher opportunity, the Company's statements regarding planned ...